OKLAHOMA CITY – Wheeler Bio, a contract development and manufacturing organization (CDMO) specializing in small batch clinical production of biologics and GMP-grade reagents using their open-source platform, Portable CMC™, today announced the first closing of their Series A financing round. The round was co-led by Charles River Laboratories and Echo Investment Capital with participation from ATUM, Floating Point Advisors, Plains Venture Partners (a subsidiary of i2E), and Pine Ridge Ventures.
The Oklahoman: NBA star Russell Westbrook adds pharmaceutical startup to growing investments in OKC
Westbrook, who played for the Oklahoma City Thunder for several years, has made multiple investments in the city since leaving the team.